Medication info

Gridm Tablet 2/500 mg

Prescription medicationExpired
Ingredient · strength
Glimepiride›Strength being verifiedMetformin Hydrochloride›Strength being verified
Manufacturer / importer
Future Bio Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201309183 · Approved 2013.09.03

This product's status changed to Expired on 2023.09.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood glucose control in type 2 diabetes
Who uses it
Adults
Adult dosage
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with experience of administration up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional effect at doses of 4mg or more per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Future Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes

  • Non-insulin dependent diabetes
View approved original text

This medication is used for patients with non-insulin dependent diabetes who are not achieving adequate blood sugar control despite dietary and exercise measures. It can provide better blood sugar management, particularly when glimepiride or metformin monotherapy is insufficient. Additionally, this drug can be used to enhance treatment efficacy as a substitute for combination therapy with glimepiride and metformin. Therefore, it helps improve diabetes management by controlling blood sugar levels.

Dosage and Administration

Adult dosage

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with experience of administration up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional effect at doses of 4mg or more per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, it should be temporarily discontinued and the doctor should be informed if renal function deteriorates abruptly or dehydration occurs. Patients with impaired renal function, severe liver dysfunction, pregnant or breastfeeding women, and those with certain cardiovascular diseases should not use this medication. Patients at high risk for hypoglycemia, such as the elderly, those with poor nutritional status or irregular meals, and those who consume alcohol heavily, should take particular care when using this medication. This medication may cause gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.), and severe symptoms may pose a risk of dehydration, so caution is warranted. Regular blood tests and kidney function evaluations are recommended, and monitoring vitamin B12 levels is also advisable. Drug interactions may occur when taken with other medications, so patients should inform their physician or pharmacist of any other medications they are taking. Alcohol consumption can increase the risk of side effects from this medication, so excessive drinking should be avoided during use. If surgery or radiological contrast tests are to be performed, this medication should be temporarily discontinued, and use should resume only after confirming normal renal function. If symptoms of hypoglycemia (headache, fatigue, tremors, dizziness, etc.) occur, immediate intake of glucose is necessary, and in severe cases, medical help should be sought. Pregnant women should avoid this medication as it may harm the fetus, and breastfeeding women should also avoid it or discontinue breastfeeding. Children and the elderly should have their renal function and overall condition closely monitored while on this medication, with particular caution to not exceed the maximum dose in the elderly. In case of overdose, severe hypoglycemia or lactic acidosis may occur, requiring immediate medical treatment. Caution is needed when driving or operating machinery, as hypoglycemia or impairment of agility may occur.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
Show 39 more
  • metallic taste
  • vision impairment
  • erythema
  • itching
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • agranulocytosis
  • pancytopenia
  • megaloblastic anemia
  • increased liver enzymes
  • liver function damage
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • abdominal pain
  • abdominal distension
  • vomiting
  • dyspepsia
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • vertigo
  • liver dysfunction
  • arthralgia
  • facial edema
  • erectile dysfunction
  • hair loss
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to prevent air exposure, and it is recommended to store it at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.